Insulet wins trade secret case against Korean insulin pump maker

Insulin pump maker Insulet won $452 million in its trade secret case against Korean rival EOFlow, the company announced on Wednesday. 

The company filed a lawsuit against EOFlow in August 2023, claiming that EOFlow copied the design for its insulin patch pump that delivers the therapy to people with diabetes. EOFlow hired several of Insulet’s former senior executives in 2016 and that, Insulet alleged, is when the company started using Insulet’s design. 

Insulet claimed it only learned of the theft in 2023 after reviewing EOFlow’s device in person. But it’s likely that Insulet decided to sue only after EOFlow became a credible competitive threat — in May of 2023, Medtronic announced plans to buy EOFlow for $738 million. Medtronic then walked away from the acquisition in December, after Insulet’s legal challenge. 

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In